Message #21 From:
NewsBot Date: October 10, 2006 05:45:00 AM
CEMI News Chembio to Hold Conference Call Today at 4:30 ET to Discuss Marketing Partner Agreements for Rapid HIV Tests
NEW YORK--(BUSINESS WIRE)--Chembio Diagnostics, Inc. (OTCBB:CEMI) will host a conference call
today, Tuesday October 10th at 4:30pm ET to
discuss the recently announced financing and marketing partner
agreements for Chembio’s rapid HIV tests.
Chembio invites all those interested in hearing management’s
discussion of the recent events to join the call by dialing (877)
407-0782. International participants may access the call by dialing
201-689-8567.
A live web cast can be accessed by clicking on the following link http://www.vcall.com/IC/CEPage.asp?ID=109970.
A replay of this web cast can also be accessed using the same link.
ABOUT CHEMBIO
Chembio Diagnostics, Inc., a developer and manufacturer of rapid
diagnostic tests for infectious diseases, is on the frontlines of the
global battle against the AIDS pandemic. The Company has received
marketing approval from the FDA for its SURE CHECK(R) HIV 1/2 and HIV
1/2 STAT-PAK(TM) rapid tests. The Company also manufactures rapid tests
for veterinary Tuberculosis and Chagas Disease, and has developed a
patent-pending technology, the Dual Path Platform (DPP(TM)), for its
next generation HIV and other rapid tests. For additional information
please visit www.chembio.com.
FORWARD-LOOKING STATEMENTS
Statements contained herein that are not historical facts may be
forward-looking statements within the meaning of the Securities Act of
1933, as amended. Forward-looking statements include statements
regarding the intent, belief or current expectations of the Company and
its management. Such statements are estimates only, as the Company has
not completed the preparation of its financial statements for those
periods, nor has its auditor completed the audit of those results.
Actual revenue may differ materially from those anticipated in this
press release. Such statements reflect management's current views, are
based on certain assumptions and involve risks and uncertainties. Actual
results, events, or performance may differ materially from the above
forward-looking statements due to a number of important factors, and
will be dependent upon a variety of factors, including, but not limited
to Chembio's ability to obtain additional financing, to obtain
regulatory approvals in a timely manner, and the demand for Chembio's
products. Chembio undertakes no obligation to publicly update these
forward-looking statements to reflect events or circumstances that occur
after the date hereof or to reflect any change in Chembio's expectations
with regard to these forward-looking statements or the occurrence of
unanticipated events. Factors that may impact Chembio's success are more
fully disclosed in Chembio's most recent public filings with the U.S.
Securities and Exchange Commission.
